Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified Cas9 system having a dominant negative effector on non-homologous end-joining fused thereto and its use for improved gene editing

Modified Cas9 system having a dominant negative effector on non-homologous end-joining fused thereto and its use for improved gene editing

US Patent 12492389 · Granted Dec 9, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Type V Cas proteins and applications thereof2025
Chimeric antigen receptors that bind to prostate specific membrane antigen2025
Biodegradable multilayer nanocapsules for the delivery of biologically active ag2024
Biodegradable multilayer nanocapsules for the delivery of biologically active ag2024
Sequence specific reagents targeting CCR5 in primary hematopoietic cells2023
Sequence specific reagents targeting CCR5 in primary hematopoietic cells2023
Sequence specific reagents targeting CCR5 in primary hematopoietic cells2023
Method for characterization of modifications caused by the use of designer nucle2022
Biodegradable multilayer nanocapsules for the delivery of biologically active ag2022
Biodegradable multilayer nanocapsules for the delivery of biologically active ag2022
Construct for epigenetic modification and its use in the silencing of genes2021
Construct for epigenetic modification and its use in the silencing of genes2021